Skip to content

PHAT - Phathom Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

Phathom Pharmaceuticals Inc

PHAT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PHATPhathom Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $18.31
52-wk low: $8.21
Prev close: $13.00
Mkt cap: $754.0M
Beta: 0.50
P/S: 3.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$132.3M

MI
Millennium
Israel Englander · Q2 2026 13F
$36.6M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Jul 30, 2026

Earnings came in 46.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -41.3%
Market cap: $754M

Valuation

P/S3.15
P/B25.37

Quality

Operating margin-5.3%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PHAT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $754.00M
Beta: 0.50

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

25.4x

Profit margin

-41.3%

Op margin

-5.3%

ROE

-3489.0%

$11.1M

position

MW

Marshall Wace

Q2 2026 13F

$7.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PHAT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.08+46.7%

-$0.15 expected

Next report

What the street expects next

-3489.0%

ROA-8.8%

Growth

Beta0.50